机器学习预测成人家族性地中海热秋水仙碱抵抗
该研究回顾性分析965例经Tel Hashomer标准诊断且基因确诊、随访至少1年的成人FMF患者,构建逻辑回归与全连接神经网络模型预测秋水仙碱抵抗。两种模型AUC均为0.79,提示AI算法在成人FMF秋水仙碱抵抗预测中具有潜力。
要点
- 逻辑回归与深度学习模型预测秋水仙碱抵抗的AUC均为0.79。
- 纯合突变型、反复关节炎、慢性关节痛、诊断年龄和发作频率在抵抗与非抵抗组间差异有统计学意义。
- 模型或可辅助成人FMF早期治疗决策与个体化策略。
核心结论
- 机器学习与深度学习算法在预测成人FMF患者秋水仙碱抵抗方面显示出显著潜力,可辅助早期治疗决策。
研究设计与样本
- 回顾性分析965例依据Tel Hashomer标准诊断且基因确诊、随访至少1年的成人FMF患者,数据按80:20分为训练集与测试集,构建逻辑回归模型和全连接神经网络,以ROC曲线下面积(AUC)等指标评估性能。
主要发现
- 逻辑回归与深度学习模型的AUC均为0.79。
- 秋水仙碱抵抗组与非抵抗组在纯合突变型(P=0.0005)、反复关节炎(P=0.0033)、慢性关节痛(P=0.0286)、诊断年龄(P=0.0022)和发作频率(P=0.0436)上差异有统计学意义。
临床怎么用
- 对具有纯合突变型、反复关节炎、慢性关节痛、诊断年龄及发作频率等特征的成人FMF患者,可借助此类模型早期识别秋水仙碱抵抗风险并个体化决策。
局限性
- 原文摘要未报告模型的外部验证、校准度及具体临床落地限制,相关局限性信息缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: FMF is a genetic autoinflammatory condition marked by recurrent fever and serositis. Colchicine is the mainstay treatment. However, 5% to 10% of patients exhibit colchicine resistance, requiring alternative therapies. Early identification of resistance is vital. While some scoring systems exist for paediatric FMF, artificial intelligence's (AI's) potential to predict colchicine resistance in adult patients with FMF has not been systematically explored. This study aimed to utilize machine-learning (ML) and deep-learning (DL) algorithms to predict colchicine resistance in adult patients with FMF. METHODS: We retrospectively analysed data from 965 adult patients with FMF diagnosed according to the Tel Hashomer criteria with genetically confirmed FMF and at least 1 year of follow-up. Data for features including mutation type, specific MEFV mutations, presence of arthritis, arthralgia, oligoarthritis, age at diagnosis, and attack frequency were selected. The data were split 80:20 for training and testing. We developed a logistic regression model and a fully connected neural network. Model performance was assessed using the Area Under the Curve (AUC) of the receiver operating characteristic (ROC) curve and other performance metrics. RESULTS: Both the logistic-regression and DL models achieved an AUC of 0.79. Statistically significant differences between colchicine-resistant and non-resistant groups were found for the homozygous mutation type (P = 0.0005), presence of recurrent arthritis (P = 0.0033), presence of chronic arthralgia (P = 0.0286), age of diagnosis (P = 0.0022), and frequency of attacks (P = 0.0436). CONCLUSION: Our findings suggest that AI-based algorithms, particularly DL models, show significant potential in predicting colchicine resistance in adult patients with FMF. These models could assist in early treatment decision-making, facilitating tailored therapeutic strategies for resistant patients.
引用
- Ozturk A, Kilic B, Kucur M, et al. Machine-learning algorithms for predicting colchicine resistance in Familial Mediterranean Fever. Rheumatology (Oxford). 2026. PMID: 41701173. doi:10.1093/rheumatology/keag096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。